The increase in the price target by HC Wainwright & Co. reflects a positive outlook on Vertex Pharmaceuticals, likely due to strong company fundamentals or potential market growth. This endorsement from a reputable analyst could lead to increased investor confidence, potentially driving up the stock price in the short term.